Related Experiment Videos

[Proceedings: Cellular immunity in autoimmune thyroid diseases: lymphocyte-mediated cytotoxicity (LMC) test]

N Amino, L J DeGroot

Nihon Naibunpi Gakkai Zasshi

|February 20, 1974

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Relation of three polymorphisms of the CTLA-4 gene in patients with Graves' disease.

Journal of endocrinological investigation·2002

Effective gene therapy for medullary thyroid carcinoma using recombinant adenovirus inducing tumor-specific expression of interleukin-12.

Gene therapy·2002

An adenoviral vector expressing functional heterogeneous proteins herpes simplex viral thymidine kinase and human interleukin-2 has enhanced in vivo antitumor activity against medullary thyroid carcinoma.

Endocrine-related cancer·2001

Adenoviral-mediated gene therapy for thyroid carcinoma using thymidine kinase controlled by thyroglobulin promoter demonstrates high specificity and low toxicity.

Thyroid : official journal of the American Thyroid Association·2001

CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease.

Journal of immunology (Baltimore, Md. : 1950)·2000

Genetic immunotherapy of established tumours with adenoviral vectors transducing murine interleukin-12 (mIL12) subunits in a rat medullary thyroid carcinoma model.

Clinical endocrinology·2000

See all related articles